期刊文献+

射频消融治疗肝癌机制的研究进展 被引量:12

Research progress in the mechanism of radiofrequency ablation in treatment of liver cancer
下载PDF
导出
摘要 射频消融作为微创治疗的方法之一,为不能行手术切除的肝脏肿瘤提供了有效的治疗手段.多项研究发现射频消融除了可以使肿瘤发生凝固性坏死,还可以促进肿瘤细胞的凋亡,抑制肿瘤的血管生成,增加肿瘤细胞的免疫原性,提高机体的抗肿瘤免疫力.本文简要论述射频消融治疗肝脏肿瘤的生物学机制. As a minimally invasive therapy, radiofrequency ablation (RFA) is used to cure the unresectable liver cancer. Many investigations demonstrated that RFA can not only result in coagulation necrosis of tumors, but also promote apoptosis of cancer cells, inhibit angiogenesis of carcinoma, improve tumor immunogenicity and elevate antitumor activity of the body. This review discusses the mechanism of RFA in treating liver cancer.
出处 《世界华人消化杂志》 CAS 北大核心 2008年第30期3416-3420,共5页 World Chinese Journal of Digestology
基金 南通市社会发展基金资助项目 No.S2006032~~
关键词 射频消融 肝脏肿瘤 治疗机制 Radio frequency ablation Liver cancer Therapeutic mechanism
  • 相关文献

参考文献10

二级参考文献92

  • 1胡永成.肿瘤局部热疗与免疫[J].国外医学(肿瘤学分册),1994,21(4):216-216. 被引量:33
  • 2谭敏,王吉甫.大肠癌患者癌周组织免疫细胞的分布及其意义[J].癌症,1996,15(4):287-289. 被引量:3
  • 3王天才,肖湘君,王思元,尹朝礼.原发性肝癌TAE前后TNF的变化[J].同济医科大学学报,1996,25(6):477-477. 被引量:4
  • 4Horie T, Dobashi K, Lizuka K, et al. Interferon-gamma rescues TNF-alpha-induced apoptosis mediated by up-regulation of TN-FR2 on Eol-cell[J]. Exphematol,1999,27(3) :512.
  • 5Rubin LA,Nelson DL. The soluble interleukin-2 receptor:biology function and clinical application[J]. Ann Intern Med, 1990,113(8):619-625.
  • 6The Liver Cancer Study Group of Japan. Predictive factors for patients with hepatocellular carcinoma in Japan [J]. Cancer,1994,74: 2722-2780.
  • 7Tsutsui S, Morita M, Kuwano H, et al. Influence of preoperative treatment and surgical operation on immune function of patients with esophageal carcinoma [J]. J Surg Oncol, 1992,49 ( 30 ): 176-185.
  • 8Nakazaki H. Properative and postoperative cytokines in patients with cancer [J]. Cancer, 1992,70(3) : 709.
  • 9Tanaka F, Otake Y, Yanagihara K, Kawano Y, Miyahara R, Li M, Yamada T, Hanaoka N, Inui K, Wada H. Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CD105 antibody. Clin Cancer Res 2001; 7:3410-3415.
  • 10Bodey B, Bodey B Jr, Siegel SE, Kaiser HE. Over-expression of endoglin (CD105): a marker of breast carcinoma-induced neovascularization. Anticancer Res 1998; 18:3621-3628.

共引文献133

同被引文献157

引证文献12

二级引证文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部